Literature DB >> 24246765

Palliative care and end-stage liver disease.

Anne M Walling1, Neil S Wenger2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24246765      PMCID： PMC3997050          DOI： 10.1016/j.cgh.2013.11.010

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  8 in total

Review 1.  Promoting declines in the prevalence of late-life disability: comparisons of three potentially high-impact interventions.

Authors:  Vicki A Freedman; Nancy Hodgson; Joanne Lynn; Brenda C Spillman; Timothy Waidmann; Anne M Wilkinson; Douglas A Wolf
Journal:  Milbank Q       Date:  2006       Impact factor: 4.911

2.  Patients on the waiting list for liver transplantation: caregiver burden and stress.

Authors:  Eliane Tiemi Miyazaki; Randolfo Dos Santos; M Cristina Miyazaki; Neide M Domingos; Hellen C Felicio; Marcia F Rocha; Paulo C Arroyo; William J Duca; Renato F Silva; Rita C M A Silva
Journal:  Liver Transpl       Date:  2010-10       Impact factor: 5.799

3.  Integrating palliative care for liver transplant candidates: "too well for transplant, too sick for life".

Authors:  Anne M Larson; J Randall Curtis
Journal:  JAMA       Date:  2006-05-10       Impact factor: 56.272

4.  Dying with end stage liver disease with cirrhosis: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment.

Authors:  K Roth; J Lynn; Z Zhong; M Borum; N V Dawson
Journal:  J Am Geriatr Soc       Date:  2000-05       Impact factor: 5.562

5.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

6.  The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.

Authors:  Jasmohan S Bajaj; James B Wade; Douglas P Gibson; Douglas M Heuman; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Michael Fuchs; Melanie B White; Debulon E Bell; HoChong Gilles; Katherine Morton; Nicole Noble; Puneet Puri; Arun J Sanyal
Journal:  Am J Gastroenterol       Date:  2011-05-10       Impact factor: 10.864

7.  The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.

Authors:  Valentina Medici; Lorenzo Rossaro; Jacob A Wegelin; Amit Kamboj; Junko Nakai; Kelli Fisher; Frederick J Meyers
Journal:  Liver Transpl       Date:  2008-08       Impact factor: 5.799

8.  Impact of consideration of transplantation on end-of-life care for patients during a terminal hospitalization.

Authors:  Anne M Walling; Steven M Asch; Karl A Lorenz; Neil S Wenger
Journal:  Transplantation       Date:  2013-02-27       Impact factor: 4.939
  8 in total
  7 in total

1.  Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010.

Authors:  Monica L Schmidt; A Sidney Barritt; Eric S Orman; Paul H Hayashi
Journal:  Gastroenterology       Date:  2015-01-23       Impact factor: 22.682

Review 2.  Palliative care for patients with end-stage liver disease.

Authors:  Anne M Larson
Journal:  Curr Gastroenterol Rep       Date:  2015-05

3.  Health related management plans improve sleep disorders of patients with chronic liver disease.

Authors:  Chunzi Liu; Hui Xie; Xin Zhang; Yanbo Yu; Xiaoning Zhang; Yanyan Sun; Lin Zhou; Beibei Su; Huaming Wang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Palliative Care and Health Care Utilization for Patients With End-Stage Liver Disease at the End of Life.

Authors:  Arpan A Patel; Anne M Walling; Joni Ricks-Oddie; Folasade P May; Sammy Saab; Neil Wenger
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-04       Impact factor: 13.576

Review 5.  Integrated Model for Patient-Centered Advanced Liver Disease Care.

Authors:  Aanand D Naik; Jennifer Arney; Jack A Clark; Lindsey A Martin; Anne M Walling; Autumn Stevenson; Donna Smith; Steven M Asch; Fasiha Kanwal
Journal:  Clin Gastroenterol Hepatol       Date:  2019-07-26       Impact factor: 13.576

6.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma.

Authors:  Tim F Greten; Ghassan K Abou-Alfa; Ann-Lii Cheng; Austin G Duffy; Anthony B El-Khoueiry; Richard S Finn; Peter R Galle; Lipika Goyal; Aiwu Ruth He; Ahmed O Kaseb; Robin Kate Kelley; Riccardo Lencioni; Amaia Lujambio; Donna Mabry Hrones; David J Pinato; Bruno Sangro; Roberto I Troisi; Andrea Wilson Woods; Thomas Yau; Andrew X Zhu; Ignacio Melero
Journal:  J Immunother Cancer       Date:  2021-09       Impact factor: 13.751

7.  How can primary care enhance end-of-life care for liver disease? Qualitative study of general practitioners' perceptions and experiences.

Authors:  Holly Standing; Helen Jarvis; James Orr; Catherine Exley; Mark Hudson; Eileen Kaner; Barbara Hanratty
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.